NMTCB study guide
Palliative Therapy:
Y-90 Microspheres - ANSWER-LIVER CANCER glass microspheres (20-30um) MAA shunting prior to therapy
Palliative Therapy:
Ra-223 Dichloride (Xofigo) - ANSWER-Prostate cancer administration every 4 weeks for 6 weeks (6 injections)
Wipe test trigger level - ANSWER-22,000dpm/100cm^2 RSO must be notified
Restricted area - ANSWER-Radiation limit > 2mrem in any one hour
Unrestricted area - ANSWER-Rad limit < 2mRem in any one hour
Palliative Therapy:
Y-90 Zevalin - ANSWER-Monoclonal antibody Radioimmunotherapy for Non-Hodgkin's lymphoma Rituximab infusion Zevalin 10 min infusion Dose < 32mCi
Caution: Radiation Area (sign) - ANSWER--Where individual can receive more than .05 msv (5mRem) in 1 hour @ 30cm -Seen in entrances to nuc med labs
Caution: High Radiation Area (sign) - ANSWER--Individual can receive more than
100mRem in 1 hour (1mSv) @ 30 cm -Commonly where radiation therapy is performed
Grave Danger: Very High Radiation Area (sign) - ANSWER-Where individual can
receive more than 500 rad (5Gy) in 1hr at 1m from source
TYPE A
DOT I label (color and regulation specifics) - ANSWER-White -no Transport Index
- / 1